The International College of Neuropsychopharmacology (CINP) is a truly global organization established over 60 years ago in Zurich, Switzerland. Our community connects biologists, researchers, psychiatrists, neurologists, pharmacologists and psychologists worldwide, enabling clinicians to hear about the latest advances in research and novel treatments, and researchers to learn about new clinical needs and challenges.
As the leading global society in our field, we collaborate actively with numerous peer group organisations and offer our members the chance to participate in specialist educational sessions and a flourishing mentor/mentee programme. Our annual World Congress acts as a forum for interdisciplinary discussion of recent breakthroughs and developments and incorporates a dedicated track for early career clinicians and researchers, including opportunities to network with global leaders in the field.
CINP’s stated objectives are as follows
- To facilitate training of psychiatrists in quantitative rating scales and ethical research methodology to enhance manpower for clinical trials worldwide
- To maintain partnership and cooperation with the worldwide pharmaceutical industry
- Critical thinking about the limits of psychopharmacology, ethical issues in psychopharmacology research, and early warning systems about side effects of psychopharmacology treatments
- To provide advice and consultation for the evaluation of all aspects of neuropsychiatric drugs, including biochemistry, pharmacology, safety and therapeutic efficacy
- To improve and advance research activities thus leading to improved patient care